logo

For the Inventor, By the Inventor

Frankfurt, Germany

Emmanuel Polymeropoulos

This inventor holds 24 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Aeterna Zentaris Gmbh, Arzneimittelwerk Dresden Gmbh, Elbion Ag. Active years: 2001-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emmanuel Polymeropoulos. Retrieved from https://idiyas.com/inventor/emmanuel-polymeropoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 4.2

 

Average Co-Inventor Count = 7.3

ph-index = 6

Forward Citations = 154(Granted Patents)


Location History:

  • Franfurt am Main, DE (2008)
  • Frankfurt-am-Main, DE (2001 - 2015)

Company Filing History:

goldMedal9 out of 36 
 
Aeterna Zentaris Gmbh
 patents
silverMedal5 out of 39 
 
Arzneimittelwerk Dresden Gmbh
 patents
bronzeMedal4 out of 9 
 
Elbion Ag
 patents
4. 2 out of 20 
 
Zentaris Ag
 patents
5. 2 out of 22 
 
Zentaris Gmbh
 patents
6. 1 out of 1 
 
Ae Zentaris Gmbh
 patent
7. 1 out of 28 
 
Biotie Therapies Corporation
 patents

Years Active: 2001-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyridopyrazine Derivatives
Signal Transduction
G-Protein Coupled Receptors
Kinase Inhibitors
Phosphodiesterase 4
Tetrahydrocarbazole
Naphthyridine Derivatives
Quinoxaline Derivatives
7-Azaindoles
Hydroxyindoles
Tyrosine Kinases
Tumor Disorders
24 patents (USPTO):Explore Patents
1. 8937068 - Pyridopyrazine derivatives and their use (2015-01-20),
2. 8604196 - Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thiourea (2013-12-10),
3. 8541462 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors (2013-09-24),
4. 8536332 - Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines (2013-09-17),
5. 8507486 - Pyridopyrazine derivatives, process of manufacturing and uses thereof (2013-08-13),
6. 8461178 - Naphthyridine derivatives and the use thereof as kinase inhibitors (2013-06-11),
7. 8394801 - Quinoxaline derivatives and their use for treating benign and malignant tumour disorders (2013-03-12),
8. 8217042 - Pyridopyrazines and their use as modulators of kinases (2012-07-10),
9. 8202883 - Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases (2012-06-19),
10. 8148546 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors (2012-04-03),
11. 8067456 - Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs) (2011-11-29),
12. 7683074 - 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them (2010-03-23),
13. 7419987 - 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them (2008-09-02),
14. 7378522 - Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone (2008-05-27),
15. 7375127 - Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) (2008-05-20),

Title: The Innovative Journey of Emmanuel Polymeropoulos

Introduction: Emmanuel Polymeropoulos is a visionary inventor based in Frankfurt, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Emmanuel Polymeropoulos holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a background in engineering and a passion for pushing the boundaries of what is possible, Emmanuel Polymeropoulos has led numerous successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Emmanuel Polymeropoulos has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and make a lasting impact on the world of innovation.

Conclusion: Emmanuel Polymeropoulos continues to inspire and drive change through his inventive mindset and dedication to creating a better future through his pioneering inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…